Ultramarathon mit Diabetes mellitus Typ 1
Abstract
Zusammenfassung. Wir berichten über einen 63-jährigen Läufer mit insulin-pflichtigem Diabetes mellitus Typ 1 seit dem 21. Lebensjahr. Im Alter von 32 Jahren lief er seinen ersten Marathon, mit 34 Jahren seinen ersten Ultramarathon. Bisher hat er über 90 Marathons und Ultramarathons bestritten. Dank einer Insulinpumpe und kontinuierlichem Glukose-Monitoring hat er bisher 48 24-h-Läufe mit einer durchschnittlichen Leistung von 133 km bestritten. Die Analyse des Trainings sowie der HbA1c-Werte zeigt eine signifikante Zunahme des monatlichen Laufvolumens, eine signifikante Abnahme des HbA1c-Werts über die Jahre sowie einen signifikanten Zusammenhang zwischen den monatlichen Laufkilometern und dem HbA1c-Wert.
Abstract. We report the case of a 63-year-old runner with type 1 diabetes mellitus requiring insulin since the age of 21. At the age of 32, he ran his first marathon, and at the age of 34 the first ultramarathon. So far, he has finished more than 90 marathons and ultramarathons. Thanks to an insulin pump and continuous glucose monitoring, he has so far completed 48 24-h-runs with an average distance of 133 km. The analysis of running volume and HbA1c values showed a significant increase in monthly exercise volume, a significant decrease in HbA1c values over the years, and a significant correlation between monthly running kilometers and HbA1c values.
Bibliografie
, : Age and ultra-marathon performance – 50 to 1,000 km distances from 1969–2012. SpringerPlus 2014; 3: 693.
, : What is the age for the fastest ultra-marathon performance in time-limited races from 6 h to 10 days? Age (Dordr) 2014; 36: 9715.
: Performance trends in 161-km ultramarathons. Int J Sports Med 2010; 31: 31–37.
: The western states 100-mile endurance run: Participation and performance trends. Med Sci Sports Exerc 2009; 41: 2191–2198.
: Participation and performance trends in 100-km ultra-marathons worldwide. J Sports Sci 2014; 32: 354–366.
: Analysis of performance and age of the fastest 100-mile ultra-marathoners worldwide. Clinics (Sao Paulo) 2013; 68: 605–611.
: Increase in finishers and improvement of performance of masters runners in the Marathon des Sables. Int J Gen Med 2013; 6: 427–438.
: Anthropometry and pre-race experience of finishers and nonfinishers in a multistage ultra-endurance run-deutschlandlauf 2007. Percept Mot Skills 2009; 109: 105–118.
, : The Transeurope Footrace Project: longitudinal data acquisition in a cluster randomized mobile MRI observational cohort study on 44 endurance runners at a 64-stage 4,486 km transcontinental ultramarathon. BMC Med 2012; 10: 78.
: Health and exercise-related medical issues among 1,212 ultramarathon runners: Baseline findings from the Ultrarunners Longitudinal TRAcking (ULTRA) Study. PLoS One 2014; 9:e83867.
: Ultramarathon runners: Nature or nurture? Int J Sports Physiol Perform 2012; 7: 310–312.
: Type 1 Diabetes mellitus and exercise in competitive athletes. Exp Clin Endocrinol Diabetes 2015; 123: 419–422.
: [Endurance capabilities of triathlon competitors with type 1 diabetes mellitus]. Dtsch Med Wochenschr. 2009; 134: 677–682.
: Sweet 452 km – a report on the first type 1 diabetes patient to finish Double Ironman, a 30-hour endurance triathlon race. Croat Med J 2013; 54: 306–307.
, : Blood glucose kinetics and physiological changes in a type 1 diabetic finisher of the Ultraman triathlon: a case study. Eur J Appl Physiol 2017; 117: 913–919.
: One year follow-up in a group of half-marathon runners with type-1 diabetes treated with insulin analogues. J Sports Med Phys Fitness 2010; 50: 506–510.
, : Continuous glucose monitoring in diabetic long distance runners. Int J Sports Med 2005; 26: 774–780.
: Marathon running does not prevent diabetes. Praxis 2017; 106: 887–892.
: Safe completion of a trail running ultramarathon by four men with type 1 diabetes. Diabetes Technol Ther 2018, 20: 147–152.
, Nyhus LK, : High-intensity aerobic interval training improves aerobic fitness and HbA1c among persons diagnosed with type 2 diabetes. Eur J Appl Physiol 2017; 117: 455–467.
: Why should people with type 1 diabetes exercise regularly? Acta Diabetol 2017; 54: 615–630.
: Continuous glucose monitoring during exercise in patients with type 1 diabetes on continuous subcutaneous insulin infusion. J Diabetes Sci Technol 2010; 4: 123–131.
: Clinical outcomes to exercise training in type 1 diabetes: A systematic review and meta-analysis. Diabetes Res Clin Pract 2017, pii: S0168–8227(17)31108–7.
, : Changes in body fat distribution and fitness are associated with changes in hemoglobin A1c after 9 months of exercise training: Results from the HART-D study. Diabetes Care 2013; 36: 2843–2849.
: Body mass index and its correlates in 1,212 ultramarathon runners: Baseline findings from the ultra study. J Phys Act Health 2014; 11: 1549–1555.
, : No damage of joint cartilage of the lower limbs in an ultra-endurance athlete – an MRI-study. BMC Musculoskelet Disord 2013; 14: 343.
, : Effect of regular exercise training on changes in HbA1c, BMI and VO2max among patients with type 2 diabetes mellitus: an 8-year trial. BMJ Open Diabetes Res Care 2017; 5: e000414.
, : Impact of lifestyle modification on glycemic control in patients with type 2 diabetes mellitus. Indian J Endocrinol Metab 2013; 17: 1030–1039.
